Safety of Dengue Vaccine?

por Biswal, Shibadas, Patel, Sanjay S, Rauscher, Martina
Publicado 2022

A common genomic code for chromatin architecture and recombination landscape

por Jabbari, Kamel, Wirtz, Johannes, Rauscher, Martina, Wiehe, Thomas
Publicado 2019

Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate

por Patel, Sanjay S, Rauscher, Martina, Kudela, Maria, Pang, Hang
Publicado 2022

Ultra Large Gene Families: A Matter of Adaptation or Genomic Parasites?

por Schiffer, Philipp H., Gravemeyer, Jan, Rauscher, Martina, Wiehe, Thomas
Publicado 2016

97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View

por Tricou, Vianney, Biswal, Shibadas, Liu, Mengya, Patel, Sanjay S, Zent, Olaf, Rauscher, Martina, Perez, Gonzalo, Kandeil, Walid, Folschweiller, Nicolas
Publicado 2021

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro...

por Tricou, Vianney, Essink, Brandon, Ervin, John E., Turner, Mark, Escudero, Ian, Rauscher, Martina, Brose, Manja, Lefevre, Inge, Borkowski, Astrid, Wallace, Derek
Publicado 2023

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City

por Biswal, Shibadas, Mendez Galvan, Jorge Fernando, Macias Parra, Mercedes, Galan-Herrera, Juan-Francisco, Carrascal Rodriguez, Monica Belisa, Rodriguez Bueno, Esteban Patricio, Brose, Manja, Rauscher, Martina, LeFevre, Inge, Wallace, Derek, Borkowski, Astrid
Publicado 2021

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

por Rivera, Luis, Biswal, Shibadas, Sáez-Llorens, Xavier, Reynales, Humberto, López-Medina, Eduardo, Borja-Tabora, Charissa, Bravo, Lulu, Sirivichayakul, Chukiat, Kosalaraksa, Pope, Martinez Vargas, Luis, Yu, Delia, Watanaveeradej, Veerachai, Espinoza, Felix, Dietze, Reynaldo, Fernando, LakKumar, Wickramasinghe, Pujitha, Duarte MoreiraJr, Edson, Fernando, Asvini D, Gunasekera, Dulanie, Luz, Kleber, Venâncioda Cunha, Rivaldo, Rauscher, Martina, Zent, Olaf, Liu, Mengya, Hoffman, Elaine, LeFevre, Inge, Tricou, Vianney, Wallace, Derek, Alera, MariaTheresa, Borkowski, Astrid
Publicado 2021

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

por López-Medina, Eduardo, Biswal, Shibadas, Saez-Llorens, Xavier, Borja-Tabora, Charissa, Bravo, Lulu, Sirivichayakul, Chukiat, Vargas, Luis Martinez, Alera, Maria Theresa, Velásquez, Hector, Reynales, Humberto, Rivera, Luis, Watanaveeradej, Veerachai, Rodriguez-Arenales, Edith Johana, Yu, Delia, Espinoza, Felix, Dietze, Reynaldo, Fernando, Lak Kumar, Wickramasinghe, Pujitha, Duarte Moreira, Edson, Fernando, Asvini D, Gunasekera, Dulanie, Luz, Kleber, da Cunha, Rivaldo Venâncio, Tricou, Vianney, Rauscher, Martina, Liu, Mengya, LeFevre, Inge, Wallace, Derek, Kosalaraksa, Pope, Borkowski, Astrid
Publicado 2020